Skip to main content
KMTS
NASDAQ Industrial Applications And Services

Officer/Director Files Intent to Sell $304K in Shares, Continuing Recent Distribution Trend

Analysis by Wiseek.ai
Sentiment info
Negative
Importance info
7
Price
$19.27
Mkt Cap
$1.233B
52W Low
$13.25
52W High
$30
Market data snapshot near publication time

summarizeSummary

An Officer and Director of Kestra Medical Technologies has filed to sell $304K worth of shares, extending a recent trend of insider selling totaling over $1.4 million in the last three months.


check_boxKey Events

  • Officer/Director Files Intent to Sell Shares

    Brian Webster, an Officer and Director, filed a Form 144 to sell 15,000 common shares.

  • Significant Proposed Sale Value

    The proposed sale is valued at approximately $304,123.49.

  • Continuation of Recent Selling Trend

    This filing extends a pattern of insider selling, with Webster having sold an additional 45,000 shares for $1.12 million in the past three months, bringing total recent dispositions to over $1.4 million.

  • Shares from Equity Compensation

    The shares intended for sale were recently acquired on January 21, 2026, as part of an issuer equity compensation plan.


auto_awesomeAnalysis

Brian Webster, an Officer and Director, has filed a Form 144 indicating intent to sell 15,000 common shares valued at approximately $304,123. This proposed sale follows a pattern of significant share dispositions by Webster, who has already sold 45,000 shares totaling over $1.1 million in the past three months. The shares intended for sale were recently acquired through a restricted share issuance as part of an equity compensation plan. This ongoing selling activity by a key insider, especially following recent disclosures of material weaknesses in internal controls, could signal a lack of conviction or a desire for liquidity, potentially creating an overhang on the stock.

At the time of this filing, KMTS was trading at $19.27 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $1.2B. The 52-week trading range was $13.25 to $30.00. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed KMTS - Latest Insights

KMTS
Apr 22, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
KMTS
Mar 17, 2026, 6:17 PM EDT
Filing Type: 144
Importance Score:
7
KMTS
Mar 17, 2026, 5:14 PM EDT
Filing Type: 10-Q
Importance Score:
8
KMTS
Mar 17, 2026, 4:04 PM EDT
Filing Type: 8-K
Importance Score:
8